[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350396-105":3,"doc-detail-350396-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","investigation-of-angiogenesis-and-epithelialmesenchymal-transition-markers-cd31-vegf-and-e-cadherin-in-prostatic-cancer-patients-a-multi-omics-study","Investigation of angiogenesis and epithelial–mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients - a multi-omics study","","Background Prostate cancer (PCa) progression is driven by angiogenesis and epithelial–mesenchymal transition (EMT), enabling tumor growth, invasion, and metastasis. However, how endothelial marker CD31 (PECAM1), VEGF, and E-cadherin act together in PCa aggressiveness is not fully clarified. Methods Seventy-eight PCa specimens were analyzed using immunohistochemistry and transcriptomic integration. Results CD31 and VEGF related to higher Gleason scores and grades, while E-cadherin loss tracked aggressiveness. Conclusions Combined biomarker patterns and pathway analyses supported prognostic stratification.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/investigation-of-angiogenesis-and-epithelialmesenchymal-transition-markers-cd31-vegf-and-e-cadherin-in-prostatic-cancer-patients-a-multi-omics-study/350396/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/investigation-of-angiogenesis-and-epithelialmesenchymal-transition-markers-cd31-vegf-and-e-cadherin-in-prostatic-cancer-patients-a-multi-omics-study/350396.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biomarkers were investigated in this study of prostatic cancer patients?","Question",{"text":63,"@type":64},"The study examined CD31 (PECAM1), VEGF, and E-cadherin. These markers were assessed using immunohistochemistry and integrated with transcriptomic analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were marker expressions related to tumor aggressiveness?",{"text":68,"@type":64},"CD31 positivity and increased VEGF scores associated with higher Gleason scores and grades, while E-cadherin expression inversely correlated with aggressiveness.",{"name":70,"@type":61,"acceptedAnswer":71},"What multi-omics approaches were used to link biomarkers with molecular pathways?",{"text":72,"@type":64},"Gene co-expression network analysis (WGCNA) identified angiogenesis-related gene modules and hub genes, and gene set enrichment analysis (GSEA) confirmed upregulation of angiogenic and EMT programs in high-grade tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350396,1790173941,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45",8,"Shahshenas et al. World Journal of Surgical Oncology (2026) 24:246  \n[https://doi.org/10.1186/s12957-026-04379-3](https://doi.org/10.1186/s12957-026-04379-3)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nInvestigation of angiogenesis and epithelial–  mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients:  \na multi-omics study  \nSina Shahshenas1, Mohammadreza Jalali Nadoushan2*, Hossein Yarmohammadi1 and Masood Soltanipur3*  \nAbstract  \nBackground Prostate cancer (PCa) progression is critically driven by angiogenesis and epithelial–mesenchymal transition (EMT), processes that facilitate tumor growth, invasion, and metastasis. However, the coordinated roles of the endothelial marker CD31 (PECAM1), VEGF, and E-cadherin in PCa aggressiveness remain to be fully elucidated. Here, we investigated the relationships among these biomarkers, Gleason score, and tumor grade, and integrated immunohistochemical (IHC) findings with transcriptomic analyses.  \nMethods Seventy-eight prostate adenocarcinoma specimens obtained via radical prostatectomy or transurethral resection (2020–2025) underwent IHC staining for CD31, VEGF, and E-cadherin. Marker expression was quantified by labeling indices, Final Staining Score (FSS), and semi-quantitative scoring, then correlated with Gleason score and grade using appropriate statistical tests (ANOVA, Mann–Whitney U, Kruskal–Wallis, correlation, logistic regression, and ROC analysis) . Bioinformatic analyses of 500 TCGA-PRAD RNA-seq samples included Weighted Gene Co-expression Network Analysis (WGCNA) to identify gene modules and hub genes, Differential gene expression (DEG), and Gene Set Enrichment Analysis (GSEA) to assess pathway enrichment.  \nResults CD31 positivity was observed in 30. 8% of cases and was associated with significantly higher Gleason scoresand grades (p \u003C 0. 01) . VEGF FSS increased stepwise with grade (p \u003C 0. 001), while E-cadherin expression inversely correlated with tumor aggressiveness (p \u003C 0. 001) . Individually, CD31 and VEGF yielded AUCs of 0.767 and 0. 680, respectively, for discriminating Gleason > 7, whereas E-cadherin loss provided the strongest inverse predictive value. The logistic regression model, integrating age with immunohistochemical expression of E-cadherin, VEGF and CD31, demonstrated strong discriminatory performance for distinguishing high-grade from low-grade tumors (AP 0 . 90, AUC 0. 95) . WGCNA identified PECAM1 as a hub in an angiogenesis-enriched module, and GSEA confirmed upregulation ofangiogenic and EMT programs in high-grade tumors.  \n*Correspondence: Mohammadreza Jalali Nadoushan [jalalinadooshan@yahoo.com](jalalinadooshan@yahoo.com)[ ](jalalinadooshan@yahoo.com)Masood Soltanipur [masood. noavaran@gmail.com](masood. noavaran@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.o","cbCaiaXxG4EgPYVS","https://ap.wps.com/l/cbCaiaXxG4EgPYVS","pdf",3613781,16,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What biomarkers were investigated in this study of prostatic cancer patients?\",\"answer\":\"The study examined CD31 (PECAM1), VEGF, and E-cadherin. These markers were assessed using immunohistochemistry and integrated with transcriptomic analyses.\"},{\"question\":\"How were marker expressions related to tumor aggressiveness?\",\"answer\":\"CD31 positivity and increased VEGF scores associated with higher Gleason scores and grades, while E-cadherin expression inversely correlated with aggressiveness.\"},{\"question\":\"What multi-omics approaches were used to link biomarkers with molecular pathways?\",\"answer\":\"Gene co-expression network analysis (WGCNA) identified angiogenesis-related gene modules and hub genes, and gene set enrichment analysis (GSEA) confirmed upregulation of angiogenic and EMT programs in high-grade tumors.\"}]","Investigation of angiogenesis and epithelial–mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients - a multi-omics study | PDF",1790088873,40,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0071310004b1925fad4a2e56a6a42973.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30f2292a18362df71b9b391b56b0caac.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a44b5fa328d6e17ce8b6bf703e29faf3.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01d7a7847e9e685b1673ba3423be19c9.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":98,"slug":143},7,"Healthcare","healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]